Publication

Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

Andrea Pfeifer
2014
Reviews

Abstract

Scientists working in the fields of Alzheimer's disease and, in particular, cognitive enhancers are very productive. The review "Cognitive enhancers (nootropics): drugs interacting with receptors" was accepted for publication in July 2012. Since then, new targets for the potential treatment of Alzheimer's disease were identified. This update describes drugs interacting with 42 receptors versus 32 receptors in the first paper. Some compounds progressed in their development, while many others were discontinued. The present review covers the evolution of research in this field through March 2014.

Official source

https://infoscience.epfl.ch/entities/publication/01a28761-43fa-43e1-bded-16f694fb5b96

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Cognitive Enhancers (Nootropics). Part 1: Drugs interacting with Receptors. Update 2014

Chat with Graph Search

Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery

Fear learning induces synaptic potentiation between engram neurons in the rat lateral amygdala

Enhancing the Signaling of GPCRs via Orthosteric Ions